Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Literatur
1.
Cai W, Chen K, He L, Cao Q, Koong A, Chen X. Quantitative PET of EGFr expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFr monoclonal antibody. Eur J Nucl Mol Imaging 2007 Jan 30; [Epub ahead of print]. DOI 10.​1007/​s00259-006-0361-6.
2.
Biasco G, Derenzini E, Grazi G, Ercolani G, Pantaleo MA, Brandi G. Treatment of hepatic metastasis from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006;32:214–28.PubMedCrossRef
3.
Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM. Imaging the pharmacodynamics of HER-2 degradation in response to Hsp90 inhibitors. Nat Biotechnolog 2004;22:701–6.CrossRef
4.
Salomon DS, Bradt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptor in human malignancies. Crit Rev Oncol Hematol 1995;19:183–232.PubMedCrossRef
5.
Piazzi G, Paterini P, Ceccarelli C, Pantaleo MA, Biasco G. Molecular determination of epidermal growth factor receptor in normal and neoplastic colrectal mucosa. Br J Cancer 2006;95:1525–8.PubMedCrossRef
6.
Mishani E, Abourbeh G, Jacobson O, Dissoki S, Ben Daniel R, Rozen Y, et al. High-affinity epidermal growth factor receptor (EGFr) irreversibile inhibitors with diminuished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFr overexpressing tumors. J Med Chem 2005;48:5337–48.PubMedCrossRef
Metadaten
Titel
PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?
verfasst von
M. A. Pantaleo
S. Fanti
P. L. Lollini
S. Boschi
G. Biasco
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0420-7

Weitere Artikel der Ausgabe 9/2007

European Journal of Nuclear Medicine and Molecular Imaging 9/2007 Zur Ausgabe

Book review

Guido Germano, Daniel Berman (eds): clinical gated cardiac SPECT

Image of the month

Unique role of radionuclide krypton-81m lung ventilation scan in critically ill children on long-term mechanical ventilation

Image of the month

Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Original Article

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

Original Article

Dual cardiac–respiratory gated PET: implementation and results from a feasibility study

Original article

A gradient-based method for segmenting FDG-PET images: methodology and validation